Abstract
Pancreatic cancer is the third most common cancer diagnosed in the United States, with more than 53,000 new cases in 2017. It is the fourth leading cause of cancer-related death in both men and women. Nonetheless, there has been no significant improvement in survival for pancreatic ductal adenocarcinoma (PDAC) patients over the past 30+ years. For this reason, there is a considerable and urgent clinical need to develop innovative strategies for effective drug delivery and treatment monitoring, resulting in improved outcomes for patients with PDAC.
This chapter describes the development of contrast-enhanced ultrasound image-guided drug delivery (CEUS-IGDD or sonoporation) to be that method and to translate it from the lab to the clinic. The initial clinical focus has been on a Phase I clinical trial for enhancing the effectiveness of standard chemotherapeutics for treatment of inoperable PDAC, which demonstrated a median survival increase from 8.9 months to 17.6 months in ten subjects augmented with sonoporation compared to 63 historical controls (p = 0.011). Recent efforts to optimize this platform and move forward to a larger Phase II clinical trial will be described.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Siegel RL, Miller KD, Jemal A (2018) Cancer statistics. CA Cancer J Clin 68(1):7–30
Cleary SP, Gryfe R, Guindi M et al (2004) Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg 198(5):722–731
Klein AP (2013) Identifying people at a high risk of developing pancreatic cancer. Nat Rev Cancer 13(1):66–74
Provenzano PP, Cuevas C, Chang AE, Goel VK, Von Hoff DD, Hingorani SR (2012) Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell 21(3):418–429
Whatcott C, Han H, Posner RG, Von Hoff DD (2013) Tumor-stromal interactions in pancreatic cancer. Crit Rev Oncog 18(1–2):135–151
Kotopoulis S, Dimcevski G, Gilja OH, Hoem D, Postema M (2013) Treatment of human pancreatic cancer using combined ultrasound, microbubbles, and gemcitabine: a clinical case study. Med Phys 40(7):072902
Dimcevski G, Kotopoulis S, Bjånes T et al (2016) A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer. J Control Release 243:172–181
Forsberg F, Stanczak M, Lyshchik A et al (2018) Subharmonic and endoscopic contrast imaging of pancreatic masses – a pilot study. J Ultrasound Med 37(1):123–129
Riall T, Cameron J, Lillemoe K et al (2005) Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma—part 3: update on 5-year survival. J Gastrointest Surg 9(9):1191–1204
Weir HK, Thun MJ, Hankey BF et al (2003) Annual report to the nation on the status of cancer, 1975–2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 95(17):1276–1299
Kooiman K, Vos HJ, Versluis M, de Jong N (2014) Acoustic behavior of microbubbles and implications for drug delivery. Adv Drug Deliv Rev 72:28–48
Lanza GM, Moonen C, Baker JR Jr et al (2014) Assessing the barriers to image-guided drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol 6(1):1–14
Lum AFH, Borden MA, Dayton PA, Kruse DE, Simon SI, Ferrara KW (2006) Ultrasound radiation force enables targeted deposition of model drug carriers loaded on microbubbles. J Control Release 111(1–2):128–134
Castle J, Butts M, Healey A, Kent K, Marino M, Feinstein SB (2013) Ultrasound-mediated targeted drug delivery: recent success and remaining challenges. Am J Physiol Heart Circ Physiol 304(3):H350–H357
Delalande A, Bouakaz A, Renault G et al (2011) Ultrasound and microbubble-assisted gene delivery in Achilles tendons: long lasting gene expression and restoration of fibromodulin KO phenotype. J Control Release 156(2):223–230
Chen Z-Y, Liang K, Qiu R-X (2010) Targeted gene delivery in tumor xenografts by the combination of ultrasound-targeted microbubble destruction and polyethyleneimine to inhibit surviving gene expression and induce apoptosis. J Exp Clin Cancer Res 29:152
Chen S, Ding J-H, Bekeredjian R et al (2006) Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology. Proc Natl Acad Sci U S A 103(22):8469–8474
Carson AR, McTiernan CF, Lavery L et al (2011) Gene therapy of carcinoma using ultrasound-targeted microbubble destruction. Ultrasound Med Biol 37(3):393–402
Carson AR, McTiernan CF, Lavery L (2012) Ultra-sound-targeted microbubble destruction to deliver siRNA cancer therapy. Cancer Res 72(23):6191–6199
Castle J, Kent K, Fan Y et al (2015) Therapeutic ultrasound: increased HDL-cholesterol following infusions of acoustic microspheres and apolipoprotein A-I plasmids. Atherosclerosis 241(1):92–99
Castle J, Feinstein SB (2014) Ultrasound-directed, site specific gene delivery. In: Jain KK (ed) Drug delivery system, 2nd edn. Springer, New York, NY
Delalande A, Kotopoulis S, Postema M, Midoux P, Pichon C (2013) Sonoporation: mechanistic insights and ongoing challenges for gene transfer. Gene 525(2):191–199
Escoffre J-M, Zeghimi A, Novell A, Bouakaz A (2013) In-vivo gene delivery by sonoporation: recent progress and prospects. Curr Gene Ther 13(1):2–14
Slikkerveer J, Kleijn SA, Appelman Y et al (2012) Ultrasound enhanced prehospital thrombolysis using microbubbles infusion in patients with acute ST elevation myocardial infarction: pilot of the sonolysis study. Ultrasound Med Biol 38(2):247–252
Bekeredjian R, Chen S, Pan W, Grayburn PA, Shohet RV (2004) Effects of ultrasound-targeted microbubble destruction on cardiac gene expression. Ultrasound Med Biol 30(4):539–543
Chen S, Shohet RV, Bekeredjian R, Frenkel P, Grayburn PA (2003) Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. J Am Coll Cardiol 42(2):301–308
Jarzabek MA, Huszthy PC, Skaftnesmo KO et al (2013) In vivo bioluminescence imaging validation of a human biopsy-derived orthotopic mouse model of glioblastoma multiforme. Mol Imaging 12(3):161–172
Phenix CP, Togtema M, Pichardo S, Zehbe I, Curiel L (2014) High intensity focused ultrasound technology, its scope and applications in therapy and drug delivery. J Pharm Sci 17(1):136–153
Goldberg B, Raichlen J, Forsberg F (2001) Ultrasound contrast agents: basic principles and clinical applications. Taylor & Francis, Abingdon
Postema M, Kotopoulis S, Delalande A, Gilja O (2012) Sonoporation: why microbubbles create pores. Ultraschall Med 33:97–98
van Wamel A, Kooiman K, Harteveld M et al (2006) Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. J Control Release 112(2):149–155
Kotopoulis S, Delalande A, Popa M et al (2014) Sonoporation-enhanced chemotherapy significantly reduces primary tumor burden in an orthotopic pancreatic cancer xenograft. Mol Imaging Biol 16(1):53–62
Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern-Cooperative-Oncology-Group. Am J Clin Oncol 5:649–655
Eisenbrey JR, Dave JK, Halldorsdottir VG et al (2011) Simultaneous grayscale and subharmonic ultrasound imaging on a modified commercial scanner. Ultrasonics 51(8):890–897
Eisenbrey JR, Sridharan A, Machado P et al (2012) Three-dimensional subharmonic ultrasound imaging in vitro and in vivo. Acad Radiol 19(6):732–739
Eisenbrey JR, Dave JK, Halldorsdottir VG et al (2013) Chronic liver disease: noninvasive subharmonic aided pressure estimation of hepatic venous pressure gradient. Radiology 268(2):581–588
Eisenbrey JR, Shaw CM, Lyshchik A et al (2015) Contrast-enhanced subharmonic and harmonic ultrasound of renal masses undergoing percutaneous cryoablation. Acad Radiol 22(7):820–826
Eisenbrey JR, Wilson CC, Ro RJ et al (2013) Correlation of ultra-sound contrast agent derived blood flow parameters with immunohistochemical angiogenesis markers in murine xenograft tumor models. Ultrasonics 53(7):1384–1391
Nam K, Eisenbrey JR, Stanczak M et al (2017) Monitoring neoadjuvant chemotherapy for breast cancer by using three-dimensional subharmonic aided pressure estimation and imaging with US contrast agents: preliminary experience. Radiology 285(1):53–62
Sridharan A, Eisenbrey JR, Liu J-B et al (2013) Perfusion estimation using contrast-enhanced 3-dimensional subharmonic ultrasound imaging: an in vivo study. Investig Radiol 48(9):654–660
Dave JK, Forsberg F (2009) Novel automated motion compensation technique for producing cumulative maximum intensity subharmonic images. Ultrasound Med Biol 35(9):1555–1563
Dave JK, Forsberg F, Fernandes S et al (2010) Static and dynamic cumulative maximum intensity display mode for subharmonic breast imaging: a comparative study with mammographic and conventional ultrasound techniques. J Ultrasound Med 29(8):1177–1185
Forsberg F, Piccoli CW, Merton DA, Palazzo JJ, Hall AL (2007) Breast lesions: imaging with contrast-enhanced subharmonic US--initial experience. Radiology 244(3):718–726
Czarnota GJ, Karshafian R, Burns PN et al (2012) Tumor radiation response enhancement by acoustical stimulation of the vasculature. Proc Natl Acad Sci U S A 109(30):E2033–E2041
Gao Y, Gao S, Zhao B, Zhao Y, Hua X, Tan K, Liu Z (2012) Vascular effects of microbubble-enhanced, pulsed, focused ultrasound on liver blood perfusion. Ultrasound Med Biol 38(1):91–98
Goertz DE, Todorova M, Mortazavi O et al (2012) Antitumor effects of combining docetaxel (taxotere) with the antivascular action of ultrasound stimulated microbubbles. PLoS One 7(12):e52307
Eisenbrey J, Merton D, Liu J, Fox T, Sridharan A, Forsberg F (2013) Ultrasound contrast agent-based vascularity measurements versus photoacoustic derived hemoglobin and oxygenation measurements in a breast cancer model (abstract). World Mol Imaging Congr 2013:P563
Eisenbrey J, Marshall A, Liu J, Sridharan A, Forsberg F (2013) Comparing photoacoustically derived hemoglobin and oxygenation measurements and ultrasound contrast agent derived vascularity measurements to immunohistochemical staining in a breast cancer xenograft model (abstract). Prog RSNA 2013:CL-MIS-MO1B
Eisenbrey JR, Merton DA, Marshall A et al (2015) Comparison of photoacoustically derived hemoglobin and oxygenation measurements with contrast-enhanced ultrasound estimated vascularity and immunohistochemical staining in a breast cancer model. Ultrason Imaging 37(1):42–52
Von Hoff DD, Ervin T, Arena FP et al (2013) Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 369(18):1691–1703
Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228–247
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Castle, J., Kotopoulis, S., Forsberg, F. (2020). Sonoporation for Augmenting Chemotherapy of Pancreatic Ductal Adenocarcinoma. In: Jain, K. (eds) Drug Delivery Systems. Methods in Molecular Biology, vol 2059. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9798-5_9
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9798-5_9
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9797-8
Online ISBN: 978-1-4939-9798-5
eBook Packages: Springer Protocols